LETROZOLE
Generic: LETROZOLE
Natco Pharma LimitedManufacturer
ORALRoute
LETROZOLEActive Substance
2011-06-03Original Approval
LETROZOLE is FDA application ANDA200161, sponsored by NATCO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
6,045 reports
2
NEUTROPENIA
4,547 reports
3
NAUSEA
4,413 reports
4
DIARRHOEA
3,850 reports
5
MALIGNANT NEOPLASM PROGRESSION
3,601 reports
6
WHITE BLOOD CELL COUNT DECREASED
3,246 reports
7
ARTHRALGIA
2,958 reports
8
ALOPECIA
2,828 reports
9
NEOPLASM PROGRESSION
2,442 reports
10
ASTHENIA
2,336 reports